REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-12-10: Form 6-K; Period of report 2024-12-10; Description 6-K; Document zk2432448.htm.
- 2024-12-02: Form 6-K; Period of report 2024-12-02; Description 6-K; Document zk2432417.htm.
- 2024-10-28: Form 6-K; Period of report 2024-10-28; Description 6-K; Document zk2432175.htm.
- 2024-10-22: Form 6-K; Period of report 2024-10-22; Description 6-K; Document zk2432165.htm.